Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Askaa

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neckJesper Grau Eriksen, Torben Steiniche, Jon Askaa, et al.
Biochimica Et Biophysica Acta|August 17, 2002
Defensin-rich granules of human neutrophils: characterization of secretory propertiesMikkel Faurschou, Ole E Sørensen, Anders H Johnsen, et al.
Frontiers in Oncology|August 9, 2021
A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric CancerJan Trøst Jørgensen, Henrik Winther, Jon Askaa, et al.
Journal of Leukocyte Biology|May 12, 2004
Localization of serglycin in human neutrophil granulocytes and their precursorsCarsten Utoft Niemann, Jack Bernard Cowland, Pia Klausen, et al.
Journal of the National Cancer Institute|August 22, 2013
Independent validation of a model using cell line chemosensitivity to predict response to therapyWenting Wang, Keith A Baggerly, Steen Knudsen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 28, 2007
Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapyTherese Phillips, Gretchen Murray, Karen Wakamiya, et al.
The Prostate|June 4, 2004
Prostein expression is highly restricted to normal and malignant prostate tissuesMichael Kalos, Jon Askaa, Bonnie L Hylander, et al.
Personalized Medicine|May 23, 2018
Market access challenges in the EU for high medical value diagnostic testsIain Miller, Joanna Ashton-Chess, Herman Spolders, et al.
Plos One|March 23, 2018
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohortsIda Kappel Buhl, Eric Santoni-Rugiu, Jesper Ravn, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neckJesper Grau Eriksen, Torben Steiniche, Jon Askaa, et al.
Biochimica Et Biophysica Acta|August 17, 2002
Defensin-rich granules of human neutrophils: characterization of secretory propertiesMikkel Faurschou, Ole E Sørensen, Anders H Johnsen, et al.
Frontiers in Oncology|August 9, 2021
A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric CancerJan Trøst Jørgensen, Henrik Winther, Jon Askaa, et al.
Journal of Leukocyte Biology|May 12, 2004
Localization of serglycin in human neutrophil granulocytes and their precursorsCarsten Utoft Niemann, Jack Bernard Cowland, Pia Klausen, et al.
Journal of the National Cancer Institute|August 22, 2013
Independent validation of a model using cell line chemosensitivity to predict response to therapyWenting Wang, Keith A Baggerly, Steen Knudsen, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 28, 2007
Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapyTherese Phillips, Gretchen Murray, Karen Wakamiya, et al.
The Prostate|June 4, 2004
Prostein expression is highly restricted to normal and malignant prostate tissuesMichael Kalos, Jon Askaa, Bonnie L Hylander, et al.
Personalized Medicine|May 23, 2018
Market access challenges in the EU for high medical value diagnostic testsIain Miller, Joanna Ashton-Chess, Herman Spolders, et al.
Plos One|March 23, 2018
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohortsIda Kappel Buhl, Eric Santoni-Rugiu, Jesper Ravn, et al.
Pageof 1